X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse TTK HEALTHCARE with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TTK HEALTHCARE   TEVA PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
TEVA PHARMA
Dec-13
TTK HEALTHCARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6632,665-   
Low Rs3992,315-   
Sales per share (Unadj.) Rs535.61,529.5-  
Earnings per share (Unadj.) Rs15.995.5-  
Cash flow per share (Unadj.) Rs20.0219.2-  
Dividends per share (Unadj.) Rs4.0083.64-  
Dividend yield (eoy) %0.83.4 22.4%  
Book value per share (Unadj.) Rs137.61,699.0-  
Shares outstanding (eoy) m7.77848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.6 60.9%   
Avg P/E ratio x33.326.1 127.8%  
P/CF ratio (eoy) x26.511.4 233.5%  
Price / Book Value ratio x3.91.5 263.4%  
Dividend payout %25.187.5 28.7%   
Avg Mkt Cap Rs m4,1272,111,647 0.2%   
No. of employees `0001.744.9 3.8%   
Total wages/salary Rs m6070-   
Avg. sales/employee Rs Th2,436.728,858.6 8.4%   
Avg. wages/employee Rs Th355.20-   
Avg. net profit/employee Rs Th72.51,802.8 4.0%   
INCOME DATA
Net Sales Rs m4,1621,297,049 0.3%  
Other income Rs m610-   
Total revenues Rs m4,2231,297,049 0.3%   
Gross profit Rs m197355,198 0.1%  
Depreciation Rs m32104,842 0.0%   
Interest Rs m3025,476 0.1%   
Profit before tax Rs m197224,880 0.1%   
Minority Interest Rs m01,022 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-147,621 0.0%   
Tax Rs m73-2,746 -2.7%   
Profit after tax Rs m12481,026 0.2%  
Gross profit margin %4.727.4 17.3%  
Effective tax rate %37.0-1.2 -3,031.4%   
Net profit margin %3.06.2 47.7%  
BALANCE SHEET DATA
Current assets Rs m1,629876,022 0.2%   
Current liabilities Rs m1,058763,965 0.1%   
Net working cap to sales %13.78.6 158.8%  
Current ratio x1.51.1 134.3%  
Inventory Days Days3091 32.8%  
Debtors Days Days3496 35.0%  
Net fixed assets Rs m556423,645 0.1%   
Share capital Rs m783,193 2.4%   
"Free" reserves Rs m8780-   
Net worth Rs m1,0691,440,775 0.1%   
Long term debt Rs m159663,210 0.0%   
Total assets Rs m2,3992,964,172 0.1%  
Interest coverage x7.69.8 77.1%   
Debt to equity ratio x0.10.5 32.2%  
Sales to assets ratio x1.70.4 396.4%   
Return on assets %6.43.6 178.4%  
Return on equity %11.65.6 206.0%  
Return on capital %18.54.9 374.2%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Net fx Rs m-300-   
CASH FLOW
From Operations Rs m127206,682 0.1%  
From Investments Rs m-146-73,236 0.2%  
From Financial Activity Rs m22-247,930 -0.0%  
Net Cashflow Rs m3-114,483 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare TTK HEALTHCARE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare TTK HEALTHCARE With: ABBOTT INDIA  MERCK LTD  BIOCON LTD  SANOFI INDIA  ORCHID PHARMA LTD  



Today's Market

Sensex Ends Above 35,000 Mark; Bank & IT Stocks Outperform(Closing)

After opening the day flat, share markets in India witnessed positive trading activity throughout the day and ended the day on a strong note.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 17, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - BIOCON LTD COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS